Long-Term Considerations For individuals needing ongoing support in maintaining healthy habits, continuing semaglutide at a lower maintenance dosage is a viable option with minimal long-term risks
Some studies indicate GLP-1s may reduce the risk of substance use disorders (Nature Medicine), neurocognitive disorders (including Alzheimers disease), infectious diseases, some respiratory conditions and certain cancers (JAMA Oncology)
For patients with established cardiovascular disease, current American Diabetes Association (ADA) guidelines recommend GLP-1 receptor agonists with proven cardiovascular benefit or SGLT2 inhibitors as preferred agents, pending cardiovascular outcomes data for tirzepatide
Slows Stomach Emptying : By slowing down the rate at which food moves from your stomach to your intestines, tirzepatide helps you feel fuller for longer, reducing hunger and supporting healthy weight loss
Check the date on every vial you receive
That dual action is why tirzepatide produces stronger results on average